Sign In
Buy RDHL
$1.00
-0.0100 (-0.99%)
At Close: Jun 03, 2026
RedHill Biopharma slumps on offering of American Depositary Shares
09:16pm, Thursday, 18'th Nov 2021 Seeking Alpha
Zacks Investment Research Downgrades RedHill Biopharma (NASDAQ:RDHL) to Sell
07:42am, Tuesday, 16'th Nov 2021 Transcript Daily
Zacks Investment Research lowered shares of RedHill Biopharma (NASDAQ:RDHL) from a hold rating to a sell rating in a research note issued to investors on Friday morning, Zacks.com reports. According to Zacks, RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the []
RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021
12:28pm, Monday, 15'th Nov 2021 InvestorsHub
RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021
TEL-AVIV, Israel and RALEIGH, N.C., November 9, 2021 -- investorsHub NewsWire -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Mr. Guy Goldberg, RedHill's Chief Business Officer, will present an overview of the Company and host 1-on-1 investor meetings...
RedHill Biopharma Ltd (NASDAQ:RDHL) has announced that the last patient has been enrolled in Part A of the Phase 2/3 study with novel, once-daily, orally-administered pill RHB-107 (upamostat) for non
RedHill Biopharma Ltd (NASDAQ:RDHL) said it has entered into a strategic investment agreement with South Korean corporation, Kukbo Co. Ltd for the sale of RedHill's American Depositary Shares (ADSs)
Why BioNTech and RedHill Are Soaring This Week, While Novavax Is Sinking
05:51am, Friday, 22'nd Oct 2021
All three have COVID-19 connections.
RDHL Stock: Why It Substantially Increased This Week
03:54pm, Tuesday, 19'th Oct 2021
The stock price of RedHill Biopharma Ltd (NASDAQ: RDHL) increased by over 18% during intraday trading this week. This is why it happened.
RedHill Biopharma Announces Insider Buying
07:02am, Monday, 18'th Oct 2021
TEL-AVIV, ISRAEL and RALEIGH, NC / ACCESSWIRE / October 18, 2021 / RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that membe
RedHill Biopharma Ltd Announces New U.S. Patent for RedHill's Talicia for H.pylori
07:02am, Tuesday, 12'th Oct 2021
RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034 The patent is directed to the Talicia® formulation and pharmaceutical kits for use in the treatment o
RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL
07:02am, Wednesday, 06'th Oct 2021
RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements Addition of Talicia® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no pri
RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements
07:00am, Wednesday, 06'th Oct 2021
TEL-AVIV, Israel and RALEIGH, N.C., Oct. 6, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.
Why RedHill Biopharma Blasted 12% Higher Today
05:46pm, Monday, 04'th Oct 2021
The company's Opaganib might have a promising future, after all.
Why Did RedHill Biopharma Shares Jump 12% Monday?
05:30pm, Monday, 04'th Oct 2021
RedHill Biopharma Ltd (NASDAQ: RDHL) has reported new data from the opaganib global Phase 2/3 study in hospitalized COVID-19 patients with severe pneumonia. Related: What's Happening With RedHil
RDHL Stock: Why It Increased Today
11:09am, Monday, 04'th Oct 2021
The stock price of RedHill Biopharma Ltd (NASDAQ: RDHL) increased by over 23% during intraday trading today. This is why it happened.
RedHill Biopharma Ltd. has reported important new data showing treatment with oral opaganib (ABC294640) versus the placebo-controlled arm resulted in a 62% statistically significant reduction in morta
